Noorani, B., Gibiansky, L., Sanghavi, K., Xu, S., Sunkersett, G., Patah, P., Mohamed, M. (2025). Optimal dose regimen of epcoritamab in combination with lenalidomide and rituximab in relapsed or refractory follicular lymphoma - analyses of pharmacokinetics and exposure-response relationships of epcore FL-1 Phase 3 study. Blood. https://doi.org/10.1182/blood-2025-1820